Functionalized Endothelial Optical Exosomes for Deep Vessel Ablation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for vascular malformations, such as Port Wine Stain, are limited due to incomplete ablation of deep dermal blood vessels and regrowth from post-treatment resistant cells, leading to inadequate clinical outcomes and challenging clinical management.
Innovation Solution
Development of functionalized endothelial optical exosomes (FEOE) using n-hDMVEC-derived exosomes loaded with therapeutic chromophores like Verteporfin or ICG, conjugated with antibodies for specific targeting of abnormal blood vessels, combined with Near-Infrared (NIR) laser therapy to destroy lesional vessels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Length of moving object
If Pulse Dye Laser (PDL) is used for treatment, then superficial blood vessels can be treated, but deep dermal blood vessels cannot be effectively reached
Solution Approach 1:
The patent uses exosomes as intermediary carriers to deliver photosensitizing agents deep into the dermis. These exosomes naturally target endothelial cells and can penetrate deep tissue barriers, serving as a mediator that bridges the gap between external laser application and deep dermal targets that conventional PDL cannot reach.
Solution Approach 2:
The patent changes the wavelength parameter from conventional PDL (585-595 nm) to Near-Infrared (NIR) wavelengths (700-900 nm), which have deeper tissue penetration capabilities. This parameter change allows the laser energy to reach deep dermal blood vessels that were previously inaccessible to standard PDL treatment.
2Reliability
If conventional PDL treatment is applied, then some blood vessels are ablated, but resistant cells lead to regrowth
Solution Approach 1:
The patent applies preliminary action by delivering photosensitizing agents via exosomes to target cells before laser activation. The exosomes pre-load the therapeutic chromophore into the endothelial cells, ensuring that when NIR laser irradiation occurs, the energy is already positioned within the target cells for maximum destructive effect, preventing resistant cell regrowth.
Solution Approach 2:
The patent replaces the purely mechanical/thermal ablation mechanism of PDL with a photodynamic therapy mechanism. Instead of relying solely on thermal damage from laser heating, the system uses photochemical reactions where photosensitizers activated by NIR light produce reactive oxygen species that selectively destroy targeted endothelial cells, providing more reliable and durable results.
3Length of moving object
If deeper penetration is achieved with NIR laser, then deep vessels are reached, but specificity of targeting may be reduced
Solution Approach 1:
The patent uses exosomes as smart intermediaries that provide biological targeting capability. These exosomes have natural tropism for endothelial cells and can be further functionalized with targeting ligands, antibodies, or peptides that specifically recognize vascular malformation markers. This intermediary system ensures that even at deep penetration depths, the therapeutic energy is delivered specifically to abnormal vessels rather than surrounding healthy tissue.
Solution Approach 2:
The patent creates a composite delivery system combining exosomes (biological carrier) with photosensitizing agents (therapeutic payload) and potentially surface-functionalized targeting moieties. This composite structure integrates deep-tissue penetration capability with high targeting specificity, as the exosome provides both the delivery vehicle and the targeting function, while the photosensitizer provides the therapeutic effect upon NIR activation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The FEOE system effectively targets and destroys abnormal blood vessels, overcoming the limitations of existing treatments by penetrating deeper into the skin and providing efficient drug delivery and specific targeting, potentially improving treatment outcomes for vascular malformations.
Implementation Method 1
exposure of the novel functionalized endothelial optical exosome to near-infrared laser irradiation may destroy lesional or abnormal blood vessels in a subject
Implementation Method 2
at least one therapeutic chromophore loaded onto the n-hDMVEC-derived exosome... exposing the novel functionalized endothelial optical exosome to near-infrared laser irradiation may destroy lesional or abnormal blood vessels
Data Source
AI summary
Described herein are systems and methods for a type of paradigm-shift nanoparticles functionalized endothelial optical exosomes for vascular malformation treatment, including Port Wine Stain, using exosomes as a drug delivery vehicle in combination with Near-Infrared-mediated laser therapy.